HFA Premium Access

Mobile cardiopaging in toxic cardiomyopathy diagnostics in cancer patients

Congress Presentation

About the speaker

Professor Nadezda Lyamina

Research Center in Rehabilitation, Restorative and Sports Medicine, Moscow (Russian Federation)
0 follower

25 more presentations in this session

Safety and tolerability of a first in class chymase inhibitor in clinically stable patients with left-ventricular dysfunction after myocardial infarction

Speaker: Doctor M. Senni (Bergamo, IT)


The relations between pro- and anti-inflammatory cytokines contractile ability of the myocardium in patients with coronary artery disease


Predictors of galectin-3 in patients with heart failure and reduced ejection fraction

Speaker: Doctor I. Alexanian (Athens, GR)


The role of Response-to-Diuretic in predicting prognosis in discharged heart failure patients after an acute decompensation.

Speaker: Doctor M. Feola (Mondovi, IT)


Use of sacubitril valsartan in heart failure due to post-chemotherapy symptomatic ventricular dysfunction

Speaker: Doctor V. Gregorietti (Buenos Aires, AR)


Access the full session

Poster Session 4 - Chronic Heart Failure – Pathophysiology and Mechanisms

Speakers: Professor N. Lyamina, Doctor M. Senni, Doctor I. Alexanian, Doctor M. Feola, Doctor V. Gregorietti

About the event


Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb